Pyrexia, commonly known as fever, is a clinical symptom frequently encountered in medical practice. It is a physiological response to a variety of conditions, most commonly infectious diseases. Understanding the pathophysiology, identifying the cause, and managing fever effectively are critical to patient care.
Pyrexia is the body's adaptive response to pathologic conditions, primarily infections. The hypothalamus, acting as the body's thermostat, raises the set-point temperature in response to pyrogens. These can be endogenous, such as cytokines, or exogenous like microbial toxins. This results in the characteristic symptoms of fever.
Identifying the cause of pyrexia is crucial for targeted treatment. A detailed history and physical examination often provide valuable clues. Laboratory tests, including complete blood count, cultures, and imaging studies, may be necessary in some cases. Infections are the most common cause, but non-infectious causes such as malignancies, autoimmune diseases, and drug reactions should also be considered.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, are commonly used for symptomatic relief. However, their use should be balanced against potential side effects. In cases where the cause of fever is unclear, empirical antimicrobial therapy may be initiated while investigations are ongoing.
Management of pyrexia may differ in special populations, such as children, pregnant women, and immunocompromised patients. In these groups, the risk of serious infections is higher, and a more cautious approach is often warranted. Additionally, the choice of antipyretics may be limited due to safety concerns.
Pyrexia is a common clinical symptom with a wide range of causes. A systematic approach to identifying the cause and managing the fever effectively is essential. Further research is needed to refine our understanding of the pathophysiology of fever and to develop more effective antipyretic therapies.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation